Arkolith/Insider Trading/OCX/Form 4

James Andrea S.

Chief Financial OfficerOncocyte Corp (OCX) · full profile →Form 4 · filed Jun 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2024Grant(A)100K—$0300K
Jun 20, 2024Grant(A)200K—$0200K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-024981) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML